Hiv Vaccine Efficacy Trials: A Brief History, And Options For Going Forward.

dc.contributor.author	McKinnon, LR
dc.contributor.author	Card, CM
dc.contributor.author	CIHR International Infectious Diseases and Global Health Training Program (IID&GHTP).
dc.date.accessioned	2013-06-27T13:28:34Z
dc.date.available	2013-06-27T13:28:34Z
dc.date.issued	2010-10
dc.identifier.citation	AIDS Rev. 2010 Oct-Dec;12(4):209-17.	en
dc.identifier.uri	http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/21179185
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/41249
dc.description.abstract	HIV vaccine research has recently produced a number of efficacy results, in addition to some promising preclinical developments. Some of these have been surprising, leading to parallel calls for a better understanding of HIV pathogenesis and immunity, while accelerating the number of candidates that can be tested empirically in clinical trials. In this review, we describe the development of three HIV vaccine efficacy trials to date, and highlight some of the possible avenues available for the field of biomedical HIV prevention to proceed.	en
dc.language.iso	en	en
dc.publisher	University of Nairobi	en
dc.title	Hiv Vaccine Efficacy Trials: A Brief History, And Options For Going Forward.	en
dc.type	Article	en
local.publisher	Department of Medical Microbiology	en